10 May 2021
This scientific brief replaces the WHO Scientific Brief entitled “’Immunity passports’ in the context of COVID-19”, published 24 April 2020.
This update is focused on what is currently understood about SARS-CoV-2 immunity from natural infection. More information about considera...tions on vaccine certificates or “passports” will be covered in an update of WHO interim guidance, as requested by the COVID-19 emergency committee.
more
First WHO Global Ministerial Conference
Ending TB in the Sustainable Development Era: A Multisectoral Response
Moscow, Russian Federation, 16-17 November 2017
Mpox, previously known as monkeypox, is a viral illness caused by the monkeypox virus (MPXV).1
It causes a painful rash, enlarged lymph nodes, fever, headache, muscle ache, back pain and low energy or feeling sick. In most cases, the symptoms of mpox go away within a few weeks with supportive care.... In some people, the illness can be severe
or lead to complications and even death.
more
Médicaments et dispositifs médicaux pour une population de
10 000 personnes pendant environ 3 mois
There has been a significant reduction in the number of displaced people - with 73,296 people currently hosted in 70 accommodation centres; down from 142,327 people the week before.
A total of 4,979 cholera cases were recorded in Beira, Dondo, Buzi and Nhamatanda and the death toll has reached eigh...t.
With UNICEF support, 814,293 people were vaccinated against cholera representing 99 per cent of the target population.
UNICEF continues supporting FIPAG (the water supply institution),
Government and operators to run water supply systems in affected areas providing drinking water to 771,856 people
more